24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma. (September 2015)

Record Type:
Journal Article
Title:
24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma. (September 2015)
Main Title:
24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma
Authors:
Long, G.V.
Dummer, R.
Ribas, A.
Puzanov, I.
Michielin, O.
Vanderwalde, A.
Andtbacka, R.H.I.
Cebon, J.
Fernandez, E.
Malvehy, J.
Olszanski, A.J.
Gajewski, T.F.
Kirkwood, J.M.
Gause, C.
Chen, L.
Kaufman, D.R.
Chou, J.
Hodi, F.S.
Abstract:
Is Part Of:
European journal of cancer. Volume 51:(2015)Supplement 3
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Issue Display:
Volume 51, Issue 3 (2015)
Year:
2015
Volume:
51
Issue:
3
Issue Sort Value:
2015-0051-0003-0000
Page Start:
S722
Page End:
Publication Date:
2015-09
Subjects:
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0959-8049(16)31944-X ↗
Languages:
English
ISSNs:
0959-8049
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
2023.xml